US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Axim Biotechnologies, Inc.

0.0065

-0.0008-10.68%

Volume:243.20K

Turnover:1.59K

Market Cap:2.17M

PE:-0.32

High:0.0069

Open:0.0065

Low:0.0065

Close:0.0073

52wk High:0.0288

52wk Low:0.0030

Shares:333.00M

Float Shares:258.00M

Volume Ratio:1.83

T/O Rate:0.09%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0206

EPS(LYR):-0.0400

ROE:-10019.09%

ROA:-36.27%

PB:-0.23

PE(LYR):-0.16

Loading ...

Overview Company News Filings

Proposed Sale Of Securities

144 - Report of proposed sale of securities

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership

Major Issues Report

8-K - Current report

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership

Major Issues Report

8-K - Current report

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]

Correspondence

CORRESP [Cover] - Correspondence

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Major Issues Report

8-K - Current report

Major Issues Report

8-K - Current report

Major Issues Report

8-K - Current report

Major Issues Report

8-K - Current report

Major Issues Report

8-K - Current report

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AXIM/filings?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AXIM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AXIM\",,,,,undefined,":{"symbol":"AXIM","market":"US","secType":"STK","nameCN":"Axim Biotechnologies, Inc.","latestPrice":0.00652,"timestamp":1774382400000,"preClose":0.0073,"halted":0,"volume":243198,"delay":15,"changeRate":-0.1068493150684932,"floatShares":258000000,"shares":333000000,"eps":-0.02057,"marketStatus":"Closed","change":-0.00078,"latestTime":"03-24 16:00:00 EDT Delay","open":0.0065,"high":0.00685,"low":0.0065,"amount":1589.89096,"amplitude":0.047945,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.02057,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774425600000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"PINK","adjPreClose":0.0073,"volumeRatio":1.833967},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AXIM\",,,,,undefined,":{"symbol":"AXIM","floatShares":258000000,"roa":"-36.27%","roe":"-10019.09%","lyrEps":-0.039999,"volumeRatio":1.833967,"shares":333000000,"dividePrice":0,"high":0.00685,"amplitude":0.047945,"preClose":0.0073,"low":0.0065,"week52Low":0.003,"pbRate":"-0.23","psRate":"23.37","week52High":0.0288,"institutionHeld":0,"latestPrice":0.00652,"eps":-0.02057,"divideRate":0,"volume":243198,"delay":15,"ttmEps":-0.02057,"open":0.0065,"prevYearClose":0.0107,"prevWeekClose":0.007,"prevMonthClose":0.0111,"prevQuarterClose":0.0107,"fiveDayClose":0.007,"twentyDayClose":0.0114,"sixtyDayClose":0.0142},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AXIM\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-08-19","symbol":"AXIM","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1724040000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-05-20","symbol":"AXIM","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1716177600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-04-16","symbol":"AXIM","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1713240000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-11-20","symbol":"AXIM","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1700456400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-08-21","symbol":"AXIM","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1692590400000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AXIM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AXIM\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v3/notice/important/events/list\",params:#symbol:\"AXIM\",pageSize:20,pageCount:2,market:\"us\",,,undefined,":[{"items":[{"cdn_pdf":false,"hasAttachments":true,"id":"15505993","market":"us","labels":[],"media":"sec.gov","original_id":"AN10747622000007-AXIM","pdf_url":"","pub_time":1665072000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"144  - Report of proposed sale of securities","symbol":"AXIM","title":"144  - Report of proposed sale of securities","titleType":"Proposed Sale Of Securities","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1514946/000010747622000007/0000107476-22-000007-index.htm","us_notice_code":"Form 144","us_title_en":"144  - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/107476/000010747622000007/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILE96RFd67tpoQEtQcH","market":"us","size":0}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Proposed Sale Of Securities","pubTime":"2022-10-07 00:00","pubTimestamp":1665072000,"title_zh":"144  - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"15467353","market":"us","labels":[],"media":"sec.gov","original_id":"AN109690622002326-AXIM","pdf_url":"","pub_time":1663862400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"SC 13D  - General statement of acquisition of beneficial ownership","symbol":"AXIM","title":"SC 13D  - General statement of acquisition of beneficial ownership","titleType":"Beneficial Ownership Change","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622002326/0001096906-22-002326-index.htm","us_notice_code":"Form SC 13D","us_title_en":"SC 13D  - General statement of acquisition of beneficial ownership","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"SCHEDULE 13D - JUNIPER & IVY CORP","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622002326/axim_sc13d.htm","primary":true,"translateUrl":"","linkName":"axim_sc13d.htm","type":"SC 13D","id":"NTFILEFdS7vsSyoxrPRQcs","market":"us","size":27438}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Beneficial Ownership Change","pubTime":"2022-09-23 00:00","pubTimestamp":1663862400,"title_zh":"SC 13D  - General statement of acquisition of beneficial ownership","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"15467355","market":"us","labels":[],"media":"sec.gov","original_id":"AN109690622002280-AXIM","pdf_url":"","pub_time":1663516800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K  - Current report","symbol":"AXIM","title":"8-K  - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622002280/0001096906-22-002280-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"SEPTEMBER 15, 2022, LICENSE AND DISTRIBUTION AGREEMENT BY AND BETWEEN AXIM BIOTE","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622002280/axim_ex10z1.htm","primary":true,"translateUrl":"","linkName":"axim_ex10z1.htm","type":"EX-10.1","id":"NTFILE7t7zZVg1xEyJwuTQ","market":"us","size":108655},{"description":"AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622002280/axim-20210915.htm","primary":false,"translateUrl":"","linkName":"axim-20210915.htm","type":"8-K","id":"NTFILEBWNrp6kiyTVzDuKN","market":"us","size":18674},{"description":"PRESS RELEASE","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622002280/axim_ex99z1.htm","primary":false,"translateUrl":"","linkName":"axim_ex99z1.htm","type":"EX-99.1","id":"NTFILE8V14ubG3CKjoi3hT","market":"us","size":13703},{"description":"IMAGE","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622002280/axim8k_1.jpg","primary":false,"translateUrl":"","linkName":"axim8k_1.jpg","type":"GRAPHIC","id":"NTFILEH3sUkqxUzWhy9pPU","market":"us","size":38710}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2022-09-19 00:00","pubTimestamp":1663516800,"title_zh":"8-K  - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"15405591","market":"us","labels":[],"media":"sec.gov","original_id":"AN109690622002069-AXIM","pdf_url":"","pub_time":1661875200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"SC 13D  - General statement of acquisition of beneficial ownership","symbol":"AXIM","title":"SC 13D  - General statement of acquisition of beneficial ownership","titleType":"Beneficial Ownership Change","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622002069/0001096906-22-002069-index.htm","us_notice_code":"Form SC 13D","us_title_en":"SC 13D  - General statement of acquisition of beneficial ownership","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"SCHEDULE 13D - CATALINA VALENCIA","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622002069/axim_sc13d.htm","primary":true,"translateUrl":"","linkName":"axim_sc13d.htm","type":"SC 13D","id":"NTFILEFADWfsAsHeFcuupG","market":"us","size":32463}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Beneficial Ownership Change","pubTime":"2022-08-31 00:00","pubTimestamp":1661875200,"title_zh":"SC 13D  - General statement of acquisition of beneficial ownership","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"15405589","market":"us","labels":[],"media":"sec.gov","original_id":"AN109690622002073-AXIM","pdf_url":"","pub_time":1661875200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"SC 13D  - General statement of acquisition of beneficial ownership","symbol":"AXIM","title":"SC 13D  - General statement of acquisition of beneficial ownership","titleType":"Beneficial Ownership Change","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622002073/0001096906-22-002073-index.htm","us_notice_code":"Form SC 13D","us_title_en":"SC 13D  - General statement of acquisition of beneficial ownership","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"SCHEDULE 13D - GLYCODOTS, LLC","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622002073/axim_sc13d.htm","primary":true,"translateUrl":"","linkName":"axim_sc13d.htm","type":"SC 13D","id":"NTFILEEwDmM2wyfHsWLHu9","market":"us","size":31365}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Beneficial Ownership Change","pubTime":"2022-08-31 00:00","pubTimestamp":1661875200,"title_zh":"SC 13D  - General statement of acquisition of beneficial ownership","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"15405587","market":"us","labels":[],"media":"sec.gov","original_id":"AN109690622002077-AXIM","pdf_url":"","pub_time":1661875200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"SC 13D/A [Amend]  - General statement of acquisition of beneficial ownership","symbol":"AXIM","title":"SC 13D/A [Amend]  - General statement of acquisition of beneficial ownership","titleType":"Beneficial Ownership Change","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622002077/0001096906-22-002077-index.htm","us_notice_code":"Form SC 13D/A","us_title_en":"SC 13D/A [Amend]  - General statement of acquisition of beneficial ownership","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"SCHEDULE 13D/A - CATALINA VALENCIA","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622002077/axim_sc13da.htm","primary":true,"translateUrl":"","linkName":"axim_sc13da.htm","type":"SC 13D/A","id":"NTFILE8fgRGi5R2kh68wbP","market":"us","size":32324}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Beneficial Ownership Change","pubTime":"2022-08-31 00:00","pubTimestamp":1661875200,"title_zh":"SC 13D/A [Amend]  - General statement of acquisition of beneficial ownership","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"15405593","market":"us","labels":[],"media":"sec.gov","original_id":"AN109690622002035-AXIM","pdf_url":"","pub_time":1661702400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K  - Current report","symbol":"AXIM","title":"8-K  - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622002035/0001096906-22-002035-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"SECURITIES PURCHASE AGREEMENT DATED AUGUST 24, 2022","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622002035/axim_ex10z1.htm","primary":true,"translateUrl":"","linkName":"axim_ex10z1.htm","type":"EX-10.1","id":"NTFILEJAfezFZxkqBTx7Xw","market":"us","size":17835},{"description":"AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622002035/axim-20220829.htm","primary":false,"translateUrl":"","linkName":"axim-20220829.htm","type":"8-K","id":"NTFILE4QpB9PTSNvowHKTv","market":"us","size":22558},{"description":"STOCK PURCHASE AGREEMENT DATED JULY 23, 2022","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622002035/axim_ex10z2.htm","primary":false,"translateUrl":"","linkName":"axim_ex10z2.htm","type":"EX-10.2","id":"NTFILE9MZAHC5YqdT8ZFsi","market":"us","size":22787},{"description":"IMAGE","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622002035/aximex10z2_1.jpg","primary":false,"translateUrl":"","linkName":"aximex10z2_1.jpg","type":"GRAPHIC","id":"NTFILE2PXyPSdpzC9MrEGr","market":"us","size":3224},{"description":"IMAGE","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622002035/aximex10z2_2.jpg","primary":false,"translateUrl":"","linkName":"aximex10z2_2.jpg","type":"GRAPHIC","id":"NTFILE7V66DtJqgBCqEuRu","market":"us","size":2492},{"description":"IMAGE","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622002035/axim8k_1.jpg","primary":false,"translateUrl":"","linkName":"axim8k_1.jpg","type":"GRAPHIC","id":"NTFILE6rPECxz6Q5G5MAbr","market":"us","size":6852}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2022-08-29 00:00","pubTimestamp":1661702400,"title_zh":"8-K  - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"15320748","market":"us","labels":[],"media":"sec.gov","original_id":"AN109690622001922-AXIM","pdf_url":"","pub_time":1660579200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"10-Q  - Quarterly report [Sections 13 or 15(d)]","symbol":"AXIM","title":"10-Q  - Quarterly report [Sections 13 or 15(d)]","titleType":"Quarterly Report","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622001922/0001096906-22-001922-index.htm","us_notice_code":"Form 10-Q","us_title_en":"10-Q  - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FORM 10-Q","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622001922/axim_10q.htm","primary":true,"translateUrl":"","linkName":"axim_10q.htm","type":"10-Q","id":"NTFILEB8kkKib2JardNcRV","market":"us","size":1611048},{"description":"CERTIFICATION","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622001922/axim_ex311.htm","primary":false,"translateUrl":"","linkName":"axim_ex311.htm","type":"EX-31.1","id":"NTFILE6dXPpYuuJC7toXPq","market":"us","size":10162},{"description":"CERTIFICATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622001922/axim_ex312.htm","primary":false,"translateUrl":"","linkName":"axim_ex312.htm","type":"EX-31.2","id":"NTFILE22PqTSmHqc8ELrvE","market":"us","size":10538},{"description":"CERTIFICATION","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622001922/axim_ex321.htm","primary":false,"translateUrl":"","linkName":"axim_ex321.htm","type":"EX-32.1","id":"NTFILEAct95gcX8EM2V3Vf","market":"us","size":3931},{"description":"CERTIFICATION","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622001922/axim_ex322.htm","primary":false,"translateUrl":"","linkName":"axim_ex322.htm","type":"EX-32.2","id":"NTFILEBpVHUdV2PqFCzaMn","market":"us","size":3890},{"description":"","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622001922/axim_10qimg2.jpg","primary":false,"translateUrl":"","linkName":"axim_10qimg2.jpg","type":"GRAPHIC","id":"NTFILE9XTJBzXxVww6B5tP","market":"us","size":5134}],"type_name":"Financial Report","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"财务报告","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"Quarterly Report","pubTime":"2022-08-16 00:00","pubTimestamp":1660579200,"title_zh":"10-Q  - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"15405594","market":"us","labels":[],"media":"sec.gov","original_id":"AN109690622001762-AXIM","pdf_url":"","pub_time":1659369600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"CORRESP [Cover] - Correspondence","symbol":"AXIM","title":"CORRESP [Cover] - Correspondence","titleType":"Correspondence","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622001762/0001096906-22-001762-index.htm","us_notice_code":"Form CORRESP","us_title_en":"CORRESP [Cover] - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622001762/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILEHFhJdk8DYqT9vkhm","market":"us","size":8435}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Correspondence","pubTime":"2022-08-02 00:00","pubTimestamp":1659369600,"title_zh":"CORRESP [Cover] - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"15263850","market":"us","labels":[],"media":"sec.gov","original_id":"AN109690622001752-AXIM","pdf_url":"","pub_time":1659369600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"S-1/A [Amend]  - General form for registration of securities under the Securities Act of 1933","symbol":"AXIM","title":"S-1/A [Amend]  - General form for registration of securities under the Securities Act of 1933","titleType":"[Amend]Public Prospectus","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622001752/0001096906-22-001752-index.htm","us_notice_code":"Form S-1/A","us_title_en":"S-1/A [Amend]  - General form for registration of securities under the Securities Act of 1933","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AXIM BIOTECHNOLOGIES, INC. - FORM S1A","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622001752/axim_s1a.htm","primary":true,"translateUrl":"","linkName":"axim_s1a.htm","type":"S-1/A","id":"NTFILEG4JmBnw5BVqg9R7k","market":"us","size":70088},{"description":"EQUITY PURCHASE AGREEMENT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622001752/axim_ex10z12.htm","primary":false,"translateUrl":"","linkName":"axim_ex10z12.htm","type":"EX-10.12","id":"NTFILE5pxVFNXGJPLup22b","market":"us","size":106362},{"description":"IMAGE","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622001752/axims1a_1.jpg","primary":false,"translateUrl":"","linkName":"axims1a_1.jpg","type":"GRAPHIC","id":"NTFILEAntRm6XsbLh3Eaa7","market":"us","size":38710}],"type_name":"Recruitment Registration","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"招股注册","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"[Amend]Public Prospectus","pubTime":"2022-08-02 00:00","pubTimestamp":1659369600,"title_zh":"S-1/A [Amend]  - General form for registration of securities under the Securities Act of 1933","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"15234800","market":"us","labels":[],"media":"sec.gov","original_id":"AN109690622001690-AXIM","pdf_url":"","pub_time":1658678400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"S-1  - General form for registration of securities under the Securities Act of 1933","symbol":"AXIM","title":"S-1  - General form for registration of securities under the Securities Act of 1933","titleType":"Public Prospectus","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622001690/0001096906-22-001690-index.htm","us_notice_code":"Form S-1","us_title_en":"S-1  - General form for registration of securities under the Securities Act of 1933","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AXIM BIOTECHNOLOGIES, INC. - FORM S-1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622001690/axim_s1.htm","primary":true,"translateUrl":"","linkName":"axim_s1.htm","type":"S-1","id":"NTFILEDgMEzAYTcdbdUmAe","market":"us","size":1895752},{"description":"FEES TABLE EXHIBIT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622001690/axim_ex107.htm","primary":false,"translateUrl":"","linkName":"axim_ex107.htm","type":"EX-FILING FEES","id":"NTFILEHgVAKzicCJ1JDDEB","market":"us","size":14280},{"description":"LEGAL OPINION OF PROCOPIO, CORY, HARGREAVES & SAVITCH LLP","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622001690/axim_ex5z1.htm","primary":false,"translateUrl":"","linkName":"axim_ex5z1.htm","type":"EX-5.1","id":"NTFILECmufg398vVM4PRo8","market":"us","size":10597},{"description":"CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622001690/axim_ex23z1.htm","primary":false,"translateUrl":"","linkName":"axim_ex23z1.htm","type":"EX-23.1","id":"NTFILEHQgQRLQxVkteoCe8","market":"us","size":2341},{"description":"IMAGE","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622001690/aximex5z1_1.jpg","primary":false,"translateUrl":"","linkName":"aximex5z1_1.jpg","type":"GRAPHIC","id":"NTFILEAiuk7P59K7BoLmUv","market":"us","size":631887},{"description":"IMAGE","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622001690/aximex5z1_2.jpg","primary":false,"translateUrl":"","linkName":"aximex5z1_2.jpg","type":"GRAPHIC","id":"NTFILEAXUANoeR21hQErMz","market":"us","size":564042},{"description":"IMAGE","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622001690/aximex5z1_3.jpg","primary":false,"translateUrl":"","linkName":"aximex5z1_3.jpg","type":"GRAPHIC","id":"NTFILEBeCuuiEWEimLVim8","market":"us","size":579598},{"description":"IMAGE","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622001690/axims1_1.jpg","primary":false,"translateUrl":"","linkName":"axims1_1.jpg","type":"GRAPHIC","id":"NTFILEFCzYKcxPBTKitpGc","market":"us","size":38710}],"type_name":"Recruitment Registration","type_name_en":"Recruitment Registration","titleTypeEn":"Public Prospectus","us_type":"招股注册","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"Public Prospectus","pubTime":"2022-07-25 00:00","pubTimestamp":1658678400,"title_zh":"S-1  - General form for registration of securities under the Securities Act of 1933","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"15038120","market":"us","labels":[],"media":"sec.gov","original_id":"AN109690622001390-AXIM","pdf_url":"","pub_time":1655136000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"S-8  - Securities to be offered to employees in employee benefit plans","symbol":"AXIM","title":"S-8  - Securities to be offered to employees in employee benefit plans","titleType":"Employee Stock Ownership","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622001390/0001096906-22-001390-index.htm","us_notice_code":"Form S-8","us_title_en":"S-8  - Securities to be offered to employees in employee benefit plans","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AXIM BIOTECHNOLOGIES, INC - FORM S-8","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622001390/axim_s8.htm","primary":true,"translateUrl":"","linkName":"axim_s8.htm","type":"S-8","id":"NTFILE5Z6UwjpDzoTvK4SQ","market":"us","size":39596},{"description":"FILING FEE TABLE","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622001390/axim_ex107.htm","primary":false,"translateUrl":"","linkName":"axim_ex107.htm","type":"EX-FILING FEES","id":"NTFILE5NLuTgtsEBBTEaxX","market":"us","size":9921},{"description":"AXIM BIOTECHNOLOGIES, INC. 2015 STOCK INCENTIVE PLAN","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622001390/axim_ex4z1.htm","primary":false,"translateUrl":"","linkName":"axim_ex4z1.htm","type":"EX-4.1","id":"NTFILE3bvNWxL6sF1RxHLq","market":"us","size":77027},{"description":"FORM OF STOCK AWARD AGREEMENT","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622001390/axim_ex4z2.htm","primary":false,"translateUrl":"","linkName":"axim_ex4z2.htm","type":"EX-4.2","id":"NTFILEBAefXKswyNLurHFX","market":"us","size":19300},{"description":"FORM OF STOCK OPTION GRANT NOTICE","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622001390/axim_ex4z3.htm","primary":false,"translateUrl":"","linkName":"axim_ex4z3.htm","type":"EX-4.3","id":"NTFILECDW43ZG2VAAUcLg5","market":"us","size":54371},{"description":"OPINION OF PHILLIP E. KOEHNKE, APC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622001390/axim_ex5z1.htm","primary":false,"translateUrl":"","linkName":"axim_ex5z1.htm","type":"EX-5.1","id":"NTFILEDCGCHS5GEsHihZ2p","market":"us","size":7081},{"description":"AMENDED AXIM BIOTECHNOLOGIES, INC. 2015 STOCK INCENTIVE PLAN","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622001390/axim_ex5z2.htm","primary":false,"translateUrl":"","linkName":"axim_ex5z2.htm","type":"EX-5.2","id":"NTFILE5nqghfE9DfskmiTt","market":"us","size":76936},{"description":"CONSENT OF RBSM LLP","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622001390/axim_ex23z1.htm","primary":false,"translateUrl":"","linkName":"axim_ex23z1.htm","type":"EX-23.1","id":"NTFILE8fFQLHjvYtFT5rRt","market":"us","size":2252}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Employee Stock Ownership","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Employee Stock Ownership","pubTime":"2022-06-14 00:00","pubTimestamp":1655136000,"title_zh":"S-8  - Securities to be offered to employees in employee benefit plans","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"14910627","market":"us","labels":[],"media":"sec.gov","original_id":"AN109690622001257-AXIM","pdf_url":"","pub_time":1653235200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"10-Q  - Quarterly report [Sections 13 or 15(d)]","symbol":"AXIM","title":"10-Q  - Quarterly report [Sections 13 or 15(d)]","titleType":"Quarterly Report","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622001257/0001096906-22-001257-index.htm","us_notice_code":"Form 10-Q","us_title_en":"10-Q  - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FORM 10-Q","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622001257/axim_10q.htm","primary":true,"translateUrl":"","linkName":"axim_10q.htm","type":"10-Q","id":"NTFILE5QYJrRgcxiYmCD13","market":"us","size":1364852},{"description":"CERTIFICATION","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622001257/axim_ex311.htm","primary":false,"translateUrl":"","linkName":"axim_ex311.htm","type":"EX-31.1","id":"NTFILE8BL43WiTS5MC7fSW","market":"us","size":11946},{"description":"CERTIFICATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622001257/axim_ex312.htm","primary":false,"translateUrl":"","linkName":"axim_ex312.htm","type":"EX-31.2","id":"NTFILE415ZS7mmSuRtRLkG","market":"us","size":11933},{"description":"CERTIFICATION","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622001257/axim_ex321.htm","primary":false,"translateUrl":"","linkName":"axim_ex321.htm","type":"EX-32.1","id":"NTFILEBNYd2CVRQUEGZfe8","market":"us","size":4469},{"description":"CERTIFICATION","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622001257/axim_ex322.htm","primary":false,"translateUrl":"","linkName":"axim_ex322.htm","type":"EX-32.2","id":"NTFILEE259HHGJhYUPopSp","market":"us","size":4426},{"description":"","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622001257/axim_10qimg2.jpg","primary":false,"translateUrl":"","linkName":"axim_10qimg2.jpg","type":"GRAPHIC","id":"NTFILEH9JVqiZWQ7j1YZka","market":"us","size":5134}],"type_name":"Financial Report","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"财务报告","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"Quarterly Report","pubTime":"2022-05-23 00:00","pubTimestamp":1653235200,"title_zh":"10-Q  - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"14625463","market":"us","labels":[],"media":"sec.gov","original_id":"AN109690622000902-AXIM","pdf_url":"","pub_time":1650297600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"10-K/A [Amend]  - Annual report [Section 13 and 15(d), not S-K Item 405]","symbol":"AXIM","title":"10-K/A [Amend]  - Annual report [Section 13 and 15(d), not S-K Item 405]","titleType":"[Rev.]Annual Report","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000902/0001096906-22-000902-index.htm","us_notice_code":"Form 10-K/A","us_title_en":"10-K/A [Amend]  - Annual report [Section 13 and 15(d), not S-K Item 405]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FORM 10-K/A","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000902/axim_10k.htm","primary":true,"translateUrl":"","linkName":"axim_10k.htm","type":"10-K/A","id":"NTFILEAhNi5VN51JuWiefr","market":"us","size":2152217},{"description":"EX-4.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000902/axim_ex41.htm","primary":false,"translateUrl":"","linkName":"axim_ex41.htm","type":"EX-4.1","id":"NTFILEGzMXSAQYhRMZysaj","market":"us","size":37691},{"description":"EX-10.7","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000902/axim_ex107.htm","primary":false,"translateUrl":"","linkName":"axim_ex107.htm","type":"EX-10.7","id":"NTFILE1EJb3t9NadNqhpjE","market":"us","size":23048},{"description":"EX-10.8","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000902/axim_ex108.htm","primary":false,"translateUrl":"","linkName":"axim_ex108.htm","type":"EX-10.8","id":"NTFILEKkzCRhcmKQ879FXF","market":"us","size":65717},{"description":"EX-10.12","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000902/axim_ex1012.htm","primary":false,"translateUrl":"","linkName":"axim_ex1012.htm","type":"EX-10.12","id":"NTFILEFWrSHY54ewyT5TTD","market":"us","size":10355},{"description":"EX-21.1","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000902/axim_ex211.htm","primary":false,"translateUrl":"","linkName":"axim_ex211.htm","type":"EX-21.1","id":"NTFILEA1AZKTK5NCnALnJP","market":"us","size":960},{"description":"EX-23.1","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000902/axim_ex231.htm","primary":false,"translateUrl":"","linkName":"axim_ex231.htm","type":"EX-23.1","id":"NTFILEHMJ6xQG8gxUeEGUU","market":"us","size":2379},{"description":"CERTIFICATION","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000902/axim_ex311.htm","primary":false,"translateUrl":"","linkName":"axim_ex311.htm","type":"EX-31.1","id":"NTFILEGKML6U7Ym2ux1Aje","market":"us","size":8487},{"description":"CERTIFICATION","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000902/axim_ex312.htm","primary":false,"translateUrl":"","linkName":"axim_ex312.htm","type":"EX-31.2","id":"NTFILE5LeMvXbwgP1S1LPz","market":"us","size":8512},{"description":"CERTIFICATION","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000902/axim_ex321.htm","primary":false,"translateUrl":"","linkName":"axim_ex321.htm","type":"EX-32.1","id":"NTFILE2gDZxXDG4cFtx11r","market":"us","size":3804},{"description":"CERTIFICATION","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000902/axim_ex322.htm","primary":false,"translateUrl":"","linkName":"axim_ex322.htm","type":"EX-32.2","id":"NTFILE28FLktKZEnCXwQPs","market":"us","size":3284},{"description":"","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000902/axim_ex1012img2.jpg","primary":false,"translateUrl":"","linkName":"axim_ex1012img2.jpg","type":"GRAPHIC","id":"NTFILEFbVHX5NeGediVwTd","market":"us","size":18366},{"description":"","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000902/axim_10kimg2.jpg","primary":false,"translateUrl":"","linkName":"axim_10kimg2.jpg","type":"GRAPHIC","id":"NTFILE2TkWcyfPqMRDCEex","market":"us","size":4231},{"description":"","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000902/axim_ex108img5.jpg","primary":false,"translateUrl":"","linkName":"axim_ex108img5.jpg","type":"GRAPHIC","id":"NTFILEEFEVbKM2kijTNJeR","market":"us","size":3808},{"description":"","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000902/axim_ex108img4.jpg","primary":false,"translateUrl":"","linkName":"axim_ex108img4.jpg","type":"GRAPHIC","id":"NTFILEConK2uteg7atPmPu","market":"us","size":10179},{"description":"","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000902/axim_ex108img3.jpg","primary":false,"translateUrl":"","linkName":"axim_ex108img3.jpg","type":"GRAPHIC","id":"NTFILEFymb5Tzdz7be765g","market":"us","size":10575},{"description":"","seq":22,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000902/axim_ex108img2.jpg","primary":false,"translateUrl":"","linkName":"axim_ex108img2.jpg","type":"GRAPHIC","id":"NTFILE8JeUuun71tJysDqX","market":"us","size":18359}],"type_name":"Financial Report","type_name_en":"Financial Report","titleTypeEn":"[Rev.]Annual Report","us_type":"财务报告","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"[Rev.]Annual Report","pubTime":"2022-04-19 00:00","pubTimestamp":1650297600,"title_zh":"10-K/A [Amend]  - Annual report [Section 13 and 15(d), not S-K Item 405","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"14602768","market":"us","labels":[],"media":"sec.gov","original_id":"AN109690622000886-AXIM","pdf_url":"","pub_time":1649952000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"10-K  - Annual report [Section 13 and 15(d), not S-K Item 405]","symbol":"AXIM","title":"10-K  - Annual report [Section 13 and 15(d), not S-K Item 405]","titleType":"Annual Report","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000886/0001096906-22-000886-index.htm","us_notice_code":"Form 10-K","us_title_en":"10-K  - Annual report [Section 13 and 15(d), not S-K Item 405]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FORM 10-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000886/axim_10k.htm","primary":true,"translateUrl":"","linkName":"axim_10k.htm","type":"10-K","id":"NTFILEEaSPCrZFQP3kEwrF","market":"us","size":1700893},{"description":"DESCRIPTION OF SECURITIES","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000886/axim_ex41.htm","primary":false,"translateUrl":"","linkName":"axim_ex41.htm","type":"EX-4.1","id":"NTFILEAkky9JcdqHtZoxfN","market":"us","size":35099},{"description":"BINDING TERM SHEET AGREEMENT","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000886/axim_ex107.htm","primary":false,"translateUrl":"","linkName":"axim_ex107.htm","type":"EX-10.7","id":"NTFILED7F1dtrVvhqbZmua","market":"us","size":25895},{"description":"ASSET PURCHASE AGREEMENT","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000886/axim_ex108.htm","primary":false,"translateUrl":"","linkName":"axim_ex108.htm","type":"EX-10.8","id":"NTFILE8y8sT68DK68qaKpm","market":"us","size":67530},{"description":"TERMINATION AGREEMENT","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000886/axim_ex1012.htm","primary":false,"translateUrl":"","linkName":"axim_ex1012.htm","type":"EX-10.12","id":"NTFILE6HyjeiGKF3KPhTAX","market":"us","size":9896},{"description":"SUBSIDIARIES","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000886/axim_ex211.htm","primary":false,"translateUrl":"","linkName":"axim_ex211.htm","type":"EX-21.1","id":"NTFILEFWmbFf3YgqWbHcKP","market":"us","size":1127},{"description":"CONSENT","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000886/axim_ex231.htm","primary":false,"translateUrl":"","linkName":"axim_ex231.htm","type":"EX-23.1","id":"NTFILE2Ci2BuvLJHizUNj1","market":"us","size":2599},{"description":"CERTIFICATION","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000886/axim_ex311.htm","primary":false,"translateUrl":"","linkName":"axim_ex311.htm","type":"EX-31.1","id":"NTFILECTy4GeL8zYQK9MLk","market":"us","size":12036},{"description":"CERTIFICATION","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000886/axim_ex312.htm","primary":false,"translateUrl":"","linkName":"axim_ex312.htm","type":"EX-31.2","id":"NTFILE5JSB6ddnkTnUeWEk","market":"us","size":12149},{"description":"CERTIFICATION","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000886/axim_ex321.htm","primary":false,"translateUrl":"","linkName":"axim_ex321.htm","type":"EX-32.1","id":"NTFILE2dEpjJw2EqJG5HuD","market":"us","size":4623},{"description":"CERTIFICATION","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000886/axim_ex322.htm","primary":false,"translateUrl":"","linkName":"axim_ex322.htm","type":"EX-32.2","id":"NTFILECCgqjGL7c125HpLM","market":"us","size":4694},{"description":"","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000886/axim_10kimg1.jpg","primary":false,"translateUrl":"","linkName":"axim_10kimg1.jpg","type":"GRAPHIC","id":"NTFILEDtMTHcXjyLhvipzT","market":"us","size":4231},{"description":"","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000886/axim_ex1012img2.jpg","primary":false,"translateUrl":"","linkName":"axim_ex1012img2.jpg","type":"GRAPHIC","id":"NTFILE8BA3qWcuAUeWReoD","market":"us","size":18367},{"description":"","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000886/axim_ex108img4.jpg","primary":false,"translateUrl":"","linkName":"axim_ex108img4.jpg","type":"GRAPHIC","id":"NTFILE3dKbfgxf7ZzL4iHD","market":"us","size":10184},{"description":"","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000886/axim_ex108img3.jpg","primary":false,"translateUrl":"","linkName":"axim_ex108img3.jpg","type":"GRAPHIC","id":"NTFILE49dGxXzLaAsL7qWc","market":"us","size":10583},{"description":"","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000886/axim_ex108img2.jpg","primary":false,"translateUrl":"","linkName":"axim_ex108img2.jpg","type":"GRAPHIC","id":"NTFILEAexXEFYgetyvvuxR","market":"us","size":18368},{"description":"","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000886/axim_ex108img1.jpg","primary":false,"translateUrl":"","linkName":"axim_ex108img1.jpg","type":"GRAPHIC","id":"NTFILEE6GxbJJRfR9KnXF2","market":"us","size":3722}],"type_name":"Financial Report","type_name_en":"Financial Report","titleTypeEn":"Annual Report","us_type":"财务报告","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"Annual Report","pubTime":"2022-04-15 00:00","pubTimestamp":1649952000,"title_zh":"10-K  - Annual report [Section 13 and 15(d), not S-K Item 405","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"14358075","market":"us","labels":[],"media":"sec.gov","original_id":"AN109690622000524-AXIM","pdf_url":"","pub_time":1646755200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K  - Current report","symbol":"AXIM","title":"8-K  - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000524/0001096906-22-000524-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.02: Termination of a Material Definitive Agreement;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRESS RELEASE","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000524/axim_ex99z1.htm","primary":true,"translateUrl":"","linkName":"axim_ex99z1.htm","type":"EX-99.1","id":"NTFILE48ivVvkdwsT9EGFr","market":"us","size":12216},{"description":"AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000524/axim-20220307.htm","primary":false,"translateUrl":"","linkName":"axim-20220307.htm","type":"8-K","id":"NTFILEESEQhxQR5rir3iW4","market":"us","size":17416},{"description":"IMAGE","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000524/axim8k_1.jpg","primary":false,"translateUrl":"","linkName":"axim8k_1.jpg","type":"GRAPHIC","id":"NTFILEDGWKNpFncDHaiVk3","market":"us","size":4297}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2022-03-09 00:00","pubTimestamp":1646755200,"title_zh":"8-K  - Current report","summary_en":"Item 1.02: Termination of a Material Definitive Agreement;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"14249587","market":"us","labels":[],"media":"sec.gov","original_id":"AN109690622000353-AXIM","pdf_url":"","pub_time":1644940800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K  - Current report","symbol":"AXIM","title":"8-K  - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000353/0001096906-22-000353-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 1.02: Termination of a Material Definitive Agreement;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FORM OF 1.5% SHORT TERM PROMISSORY NOTES DATED FEBRUARY 10, 2022","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000353/axim_ex10z1.htm","primary":true,"translateUrl":"","linkName":"axim_ex10z1.htm","type":"EX-10.1","id":"NTFILE76NErryYe4AcGw1a","market":"us","size":17657},{"description":"AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000353/axim-20220210.htm","primary":false,"translateUrl":"","linkName":"axim-20220210.htm","type":"8-K","id":"NTFILEHfgYCARmLrPrL4JU","market":"us","size":26174},{"description":"FORM OF 3% SHORT TERM CONVERTIBLE NOTES DATED FEBRUARY 10, 2022","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000353/axim_ex10z2.htm","primary":false,"translateUrl":"","linkName":"axim_ex10z2.htm","type":"EX-10.2","id":"NTFILECE1nbm9KLdAC2tJJ","market":"us","size":27837},{"description":"6% CONVERTIBLE REDEEMABLE NOTE DATED SEPTEMBER 29, 2021, MADE BY AND BETWEEN AXI","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000353/axim_ex10z3.htm","primary":false,"translateUrl":"","linkName":"axim_ex10z3.htm","type":"EX-10.3","id":"NTFILE5rpbZAq7NKschRx4","market":"us","size":59127},{"description":"IMAGE","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000353/axim8k_1.jpg","primary":false,"translateUrl":"","linkName":"axim8k_1.jpg","type":"GRAPHIC","id":"NTFILE4NtSJCD9abyYWc4W","market":"us","size":4297}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2022-02-16 00:00","pubTimestamp":1644940800,"title_zh":"8-K  - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 1.02: Termination of a Material Definitive Agreement;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"13909391","market":"us","labels":[],"media":"sec.gov","original_id":"AN109690622000092-AXIM","pdf_url":"","pub_time":1641916800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K  - Current report","symbol":"AXIM","title":"8-K  - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000092/0001096906-22-000092-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"IMAGE","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000092/axim8k_1.jpg","primary":true,"translateUrl":"","linkName":"axim8k_1.jpg","type":"GRAPHIC","id":"NTFILEBjzYRXaJS31TqjJH","market":"us","size":5076},{"description":"AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000092/axim-20220106.htm","primary":false,"translateUrl":"","linkName":"axim-20220106.htm","type":"8-K","id":"NTFILEHSaWB1Cui1iS1Pd2","market":"us","size":15995}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2022-01-12 00:00","pubTimestamp":1641916800,"title_zh":"8-K  - Current report","summary_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"13909392","market":"us","labels":[],"media":"sec.gov","original_id":"AN109690622000068-AXIM","pdf_url":"","pub_time":1641484800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K  - Current report","symbol":"AXIM","title":"8-K  - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000068/0001096906-22-000068-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"IMAGE","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000068/axim8k_1.jpg","primary":true,"translateUrl":"","linkName":"axim8k_1.jpg","type":"GRAPHIC","id":"NTFILEAq4t8mRv4xgFPktS","market":"us","size":4297},{"description":"AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622000068/axim-20220104.htm","primary":false,"translateUrl":"","linkName":"axim-20220104.htm","type":"8-K","id":"NTFILEGWLNVbPRtw2bxhcG","market":"us","size":14908}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2022-01-07 00:00","pubTimestamp":1641484800,"title_zh":"8-K  - Current report","summary_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"13764342","market":"us","labels":[],"media":"sec.gov","original_id":"AN107878221000441-AXIM","pdf_url":"","pub_time":1620921600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K  - Current report","symbol":"AXIM","title":"8-K  - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1514946/000107878221000441/0001078782-21-000441-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 10.1 EQUITY PURCHASE AGREEMENT, DATED MAY 14, 2021, BY AND BETWEEN THE C","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000107878221000441/f8k051421_ex10z1.htm","primary":true,"translateUrl":"","linkName":"f8k051421_ex10z1.htm","type":"EX-10.1","id":"NTFILEEATLpcpEionA5pKm","market":"us","size":120138},{"description":"FORM 8K CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1514946/000107878221000441/f8k051421_8k.htm","primary":false,"translateUrl":"","linkName":"f8k051421_8k.htm","type":"8-K","id":"NTFILEY3q4GQ3bEEjd38ZC","market":"us","size":18716}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2021-05-14 00:00","pubTimestamp":1620921600,"title_zh":"8-K  - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":99,"code":"91000000","status":"200"}]}}